- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
Patent holdings for IPC class A61K 31/593
Total number of patents in this class: 1273
10-year publication summary
140
|
117
|
131
|
136
|
129
|
142
|
181
|
150
|
119
|
47
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Wisconsin Alumni Research Foundation | 3867 |
43 |
DSM IP Assets B.V. | 5661 |
40 |
EirGen Pharma Limited | 85 |
38 |
Société des Produits Nestlé S.A. | 9190 |
36 |
LEO Pharma A/S | 431 |
17 |
N.V. Nutricia | 1055 |
15 |
Journey Medical Corporation | 93 |
13 |
AMBO Innovations, LLC | 29 |
11 |
Opko Ireland Global Holdings, Ltd. | 19 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6347 |
10 |
Nulixir Inc. | 39 |
10 |
Nestec S.A. | 2680 |
9 |
Ldn Pharma Limited | 42 |
9 |
The Trustees of the University of Pennsylvania | 4304 |
8 |
Albert Einstein College of Medicine, Inc. | 573 |
8 |
Matthias W. Rath | 24 |
8 |
URGO Recherche Innovation et Developpement | 296 |
8 |
Nutri Co., Ltd. | 48 |
7 |
Massachusetts Institute of Technology | 10002 |
6 |
Opko Renal, LLC | 8 |
6 |
Other owners | 960 |